Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-006070
Filing Date
2025-04-25
Accepted
2025-04-25 06:05:05
Documents
2
Period of Report
2025-04-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4792
2 ex24.htm EX-24 9640
  Complete submission text file 0001641172-25-006070.txt   16022
Mailing Address C/O INNOVIVE PHARMACEUTICALS, INC. 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
Poma Eric E (Reporting) CIK: 0001339484 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40789 | Film No.: 25869746

Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Issuer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)